Mullen W, Graf BA, Caldwell ST, Hartley RC, Duthie GG, Edwards CA, Lean ME,
Crozier A. Determination of flavonol metabolites in plasma and tissues of rats by
HPLC-radiocounting and tandem mass spectrometry following oral ingestion of
[2-(14)C]quercetin-4^0 -glucoside. J Agric Food Chem 2002;50:6902–6909.
Mullen W, Hartley RC, Crozier A. Detection and identification of 14C-labeled flavonol
metabolites by high-performance liquid chromatography-radiocounting and tandem
mass spectrometry. J Chromatogr A 2003;1007:21–29.
Nassar AE, Bjorge SM, Lee DY. On-line liquid chromatography-accurate radioisotope
counting coupled with a radioactivity detector and mass spectrometer for metabolite
identification in drug discovery and development. Anal Chem 2003;75:785–790.
Nassar AE, Parmentier Y, Martinet M, Lee DY. Liquid chromatography-accurate
radioisotope counting and microplate scintillation counter technologies in drug
metabolism-studies. J Chromatogr Sci 2004;42:348–353.
Nedderman AN, Savage ME, White KL, Walker DK. The use of 96-well Scintiplates to
facilitate definitive metabolism studies for drug candidates. J Pharm Biomed Anal
2004;34:607–617.
Staack RF and Hopfgarner G. New analytical strategies in drug metabolism. Anal
Bioanal Chem 2007;388:1365–1380.
Thompson DC, Perera K, London R. Quinone methide formation from para isomers of
methylphenol (cresol), ethylphenol, and isopropylphenol: relationship to toxicity.
Chem Res Toxicol 1995;8:55–60.
Veltkamp AC. Radiochromatography in pharmaceutical and biomedical analysis. J
Chromatogr 1990;531:101–129.
Vlasakova V, Brezinova A, Holik J. Study of cytokinin metabolism using HPLC with
radioisotope detection. J Pharm Biomed Anal 1998;17:39–44.
Wallace D, Hildesheim A, Pinto LA. Comparison of benchtop microplate beta counters
with the traditional gamma counting method for measurement of chromium-51
release in cytotoxic assays. Clin Diagn Lab Immunol 2004;11:255–260.
Wang G, Hsieh Y, Cui X, Cheng KC, Korfmacher WA. Ultra-performance liquid
chromatography/tandem mass spectrometric determination of testosterone and
its metabolites inin vitrosamples. Rapid Commun Mass Spectrom 2006a;20:2215–
2221.
Wang J, Zhao X, Zheng Y, Kong H, Lu G, Cai Z, Xu G. Metabolite fingerprint and
biomarkers identification of rat urine after dosed with ginsenoside Rg3 based on
ultra high performance liquid chromatography/time-of-flight mass spectrometry
(UPLC/TOF-MS)]. Se Pu 2006b;24:5–9.
White IN, Brown K. Techniques: the application of accelerator mass spectrometry to
pharmacology and toxicology. Trends Pharmacol Sci 2004;25:442–447.
Zhang D, Krishna R, Wang L, Zeng J, Mitroka J, Dai R, Narasimhan N, Reeves RA,
Srinivas NR, Klunk LJ. Metabolism, pharmacokinetics, and protein covalent
binding of radiolabeled MaxiPost (BMS-204352) in humans. Drug Metab Dispos
2005;33:83–93.
Zhang D, Ogan M, Gedamke R, Roongta V, Dai R, Zhu M, Rinehart JK, Klunk L,
Mitroka J. Protein covalent binding of maxipost through a cytochrome P450-
mediated orthoquinone methide intermediate in rats. Drug Metab Dispos
2003;31:837–845.
316 APPLICATIONS OF LIQUID RADIOCHROMATOGRAPHY TECHNIQUES